Combination of bupropion and naltrexone caused much greater decreased in intake of food, producing synergistic effect more than additive effect [39]
45 CalabreseV.CorneliusC.MancusoC.LentileR.StellaA
Cardiovascular Benefits: Semaglutide has shown potential in reducing cardiovascular risk factors, making it an attractive option for individuals with obesity-related heart health concerns
In addition to having a 20% lower risk overall of major cardiac events, such as heart attack, stroke, or cardiovascular death, participants who took Wegovy had a 28% reduction in heart attacks (for those already taking heart medications, such as statins, to reduce cholesterol), a 7% decrease in non-fatal strokes, and a 15% drop in cardiovascular-related deaths
The peripheral neuropathy in Fabry disease is described as a small fibre neuropathy, meaning that small, unmyelinated nerve fibres are particularly affected [82]
Yes, and thats what I think a GLP-1 does